Excedrin Extra Strength Pain Reliever is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.
| Product ID | 0067-8203_0faa3592-4d56-4645-9a0e-066e0bdfebb6 |
| NDC | 0067-8203 |
| Product Type | Human Otc Drug |
| Proprietary Name | Excedrin Extra Strength Pain Reliever |
| Generic Name | Acetaminophen, Aspirin (nsaid), And Caffeine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-03-09 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Active Ingredient Strength | 250 mg/1; mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-01-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 29485-8026 | EXCEDRIN EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN, and CAFFEINE |
| 29485-8027 | EXCEDRIN EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN, and CAFFEINE |
| 0067-2000 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 0067-2001 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 0067-8202 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 0067-8203 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 53808-0834 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 70518-3399 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
| 52904-868 | Excedrin Extra Strength | acetaminophen, aspirin (nsaid), and caffeine |
| 0067-8151 | Excedrin Extra Strength and Excedrin Tension Headache | Acetaminophen, Aspirin (NSAID), and Caffeine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EXCEDRIN 98594008 not registered Live/Pending |
Haleon CH SARL 2024-06-10 |
![]() EXCEDRIN 97425413 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-05-24 |
![]() EXCEDRIN 97210682 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
![]() EXCEDRIN 97210676 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
![]() EXCEDRIN 86434099 4978864 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2014-10-24 |
![]() EXCEDRIN 85243455 3985911 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2011-02-16 |
![]() EXCEDRIN 74504161 1892912 Dead/Cancelled |
Bristol-Myers Squibb Company 1994-03-23 |
![]() EXCEDRIN 73661685 1472811 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1987-05-18 |
![]() EXCEDRIN 72080162 0696323 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1959-08-25 |